| 000 | 01471 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514022527.0 | ||
| 264 | 0 | _c20020618 | |
| 008 | 200206s 0 0 eng d | ||
| 022 | _a0022-3573 | ||
| 024 | 7 |
_a10.1211/0022357011778214 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJohnson, B M | |
| 245 | 0 | 0 |
_aThe impact of P-glycoprotein efflux on enterocyte residence time and enterocyte-based metabolism of verapamil. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacy and pharmacology _cDec 2001 |
||
| 300 |
_a1611-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAryl Hydrocarbon Hydroxylases |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xmetabolism |
| 650 | 0 | 4 | _aCytochrome P-450 CYP3A |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xphysiology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnterocytes _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOxidoreductases, N-Demethylating _xphysiology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVerapamil _xmetabolism |
| 700 | 1 | _aCharman, W N | |
| 700 | 1 | _aPorter, C J | |
| 773 | 0 |
_tThe Journal of pharmacy and pharmacology _gvol. 53 _gno. 12 _gp. 1611-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1211/0022357011778214 _zAvailable from publisher's website |
| 999 |
_c11715168 _d11715168 |
||